|4Jul 1, 5:52 PM ET

Berger Mark Stanley 4

4 · Genprex, Inc. · Filed Jul 1, 2025

Insider Transaction Report

Form 4
Period: 2025-06-30
Berger Mark Stanley
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2025-06-30$0.23/sh4,500$1,02617,971 total
Footnotes (1)
  • [F1]Represents shares withheld on June 30, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4